rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2008-7-14
|
pubmed:abstractText |
Epithelial-to-mesenchymal transition contributes to renal fibrogenesis, which is regulated by profibrogenic and antifibrogenic mediators. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors can prevent epithelial-to-mesenchymal transition in some models. Therefore, we tested the hypothesis that epithelial-to-mesenchymal transition participates in renal injury in porcine atherosclerotic renovascular disease and can be attenuated by simvastatin.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0263-6352
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1651-60
|
pubmed:meshHeading |
pubmed-meshheading:18622245-Animals,
pubmed-meshheading:18622245-Atherosclerosis,
pubmed-meshheading:18622245-Blood Pressure,
pubmed-meshheading:18622245-Disease Models, Animal,
pubmed-meshheading:18622245-Epithelial Cells,
pubmed-meshheading:18622245-Fibrosis,
pubmed-meshheading:18622245-Glomerular Filtration Rate,
pubmed-meshheading:18622245-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:18622245-Hypertension, Renal,
pubmed-meshheading:18622245-Mesenchymal Stem Cells,
pubmed-meshheading:18622245-Renal Artery Obstruction,
pubmed-meshheading:18622245-Renal Circulation,
pubmed-meshheading:18622245-Simvastatin,
pubmed-meshheading:18622245-Sus scrofa
|
pubmed:year |
2008
|
pubmed:articleTitle |
Simvastatin abates development of renal fibrosis in experimental renovascular disease.
|
pubmed:affiliation |
Department of Internal Medicine (Divisions of Nephrology and Hypertension), Mayo Clinic, Rochester, Minnesota 55905, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|